EurekAlert! -
4 Oct 2017 06:00
(UNC Lineberger Comprehensive Cancer Center) Preliminary findings presented at this year's American Society of Radiation Oncology Annual Meeting suggest a genetic test for HPV16 in the blood could be useful to help assess risk for patients, and could help identify patients suitable for lower treatment doses.
Share this Article